OBUS NELSON

CIK 000101704331 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001017043

Recent Transactions

50 trades

Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2025-07-15+19,506→ 138,193 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2024-07-08+30,000→ 118,687 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2024-02-01−9,554→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2024-02-01+9,554→ 88,687 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2023-06-01+18,182→ 79,133 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2023-05-31−9,474→ 0 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2023-05-31+9,474→ 60,951 total
Award
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2023-02-02+85,821→ 381,706 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2023-02-01+9,554→ 9,554 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2022-09-01$1.65/sh+2,225→ 6,461,332 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2022-08-31$1.65/sh+951→ 6,459,107 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2022-08-29$1.65/sh+9,543→ 6,458,156 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2022-08-26$1.65/sh+40,007→ 6,448,613 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2022-06-04$9.50/sh+7,059→ 51,477 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2022-06-04$9.50/sh−7,059→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2022-05-31+9,474→ 9,474 total
Award
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2022-02-03+48,649→ 295,885 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2021-12-08$3.25/sh+431→ 6,408,606 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2021-12-06$3.24/sh+6,603→ 6,408,175 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2021-12-03$3.24/sh+2,966→ 6,401,572 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2021-08-23$4.03/sh+46,700→ 6,398,606 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2021-06-04+7,059→ 7,059 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2021-06-01$11.64/sh+8,303→ 44,418 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2021-06-01$11.64/sh−8,303→ 0 total
Award
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2021-02-04+27,398→ 247,236 total
Purchase
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2021-01-12$10.74/sh+13,600→ 2,905,300 total
Purchase
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2021-01-11$10.81/sh+6,400→ 2,891,700 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-11-24$1.75/sh+500→ 6,351,906 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-11-19$1.75/sh+1,900→ 6,351,406 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-11-18$1.75/sh+1,400→ 6,349,506 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-11-17$1.75/sh+300→ 6,348,106 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-11-16$1.74/sh+1,775→ 6,347,806 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2020-10-15$10.36/sh+2,200→ 36,115 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2020-10-15−2,200→ 0 total
Purchase
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2020-10-14$10.32/sh+8,638→ 2,885,300 total
Purchase
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2020-10-13$10.19/sh+1,362→ 2,876,662 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-08-26$1.68/sh+850→ 6,346,031 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-08-25$1.68/sh+32,500→ 6,345,181 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-08-21$1.75/sh+20,000→ 6,312,681 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-08-19$1.78/sh+20,000→ 6,292,681 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-06-17$1.25/sh+150,000→ 6,272,681 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-06-03$1.14/sh+87,989→ 6,122,681 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2020-06-01+8,303→ 8,303 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2020-05-28$10.99/sh+6,000→ 33,915 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2020-05-28−6,000→ 0 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-05-28$1.10/sh+31,011→ 6,034,692 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-05-22$1.01/sh+200,000→ 6,003,681 total
Purchase
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-05-20$1.00/sh+35,100→ 5,803,681 total
Purchase
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2020-05-11$10.80/sh+5,000→ 2,875,300 total
Award
NOS4-1, Inc.
Common Stock, $0.01 par value per share
2020-03-13+73,171→ 219,838 total

Companies

Recent Filings

Address

450 SEVENTH AVENUE SUITE 509

NEW YORK, NY, 10123

View on SEC.gov